Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma.
Ken OgasawaraMichael DoddsTimothy MackJames LympJustine Dell'AringaJeff SmithPublished in: Clinical pharmacokinetics (2021)
NCT02631044.